1 / 42

Anti-bacteria Medicine

Anti-bacteria Medicine. Anti-bacteria medicine. Antibiotics: The substance derived from fungi and bacteria which can selectively kill or inhibit bacteria growth Anti-bacteria medicine: Chemically synthesized medicine which can selectively kill or inhibit bacteria growth. Antibacteria medicine.

fagan
Download Presentation

Anti-bacteria Medicine

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Anti-bacteria Medicine

  2. Anti-bacteria medicine • Antibiotics: The substance derived from fungi and bacteria which can selectively kill or inhibit bacteria growth • Anti-bacteria medicine: Chemically synthesized medicine which can selectively kill or inhibit bacteria growth

  3. Antibacteria medicine • Sulfonamide • Quilonones • others

  4. Antibiotics and drugs targeting nucleic acid biosynthesis and functions

  5. Antibiotics and drugs targeting nucleic acid biosynthesis and functions 1. Sulphonamides & Trimethoprim (TMP) PABA false structure Inhibition of Dihydrofolate reductase Dihydrofolate  tetrahydrofolate

  6. Antibiotics and drugs targeting nucleic acid biosynthesis and functions 2. Quinolones Bacterial topoisomerase II- Gyrase • Nalidixic acid • Ofloxacin • Ciprofloxacin

  7. Antibiotics and drugs targeting nucleic acid biosynthesis and functions 3. Rifampicin (from rifamycin)  subunit of DNA-primed RNA polymease

  8. Antibiotics and drugs targeting nucleic acid biosynthesis and functions ! Rifampicin must be given by a “cocktail” of drugs.

  9. Problem of antibiotics which inhibit protein synthesis

  10. Antibiotics: From isolation of strain to clinical application • Selection of a potential product 1、efficacy 2、metabolic characterization 3、toxicity and adverse effect 4、Potentiality of industrial production

  11. Antibiotics: from strain isolation to clinical application • Semi-synthesis: the most popular approach of production • Marketing potentiality • Life-span of marketing and its impact

  12. Patients withpneumonia and bacteria in blood Penicillin % överlevare Penicillin increased the chance of survival from 10% to 90% Obehandlade Dagar

  13. “It is not difficult to make microbes resistant to penicillin… “ “The time may come when penicillin can be bought by anyone in the shops“ Alexander Fleming's Nobel Lecture, 1945

  14. The Global Challenge Antibioticshavesaved millions of lives Antibiotics are rapidlylosingtheireffect

  15. What is Antibiotic Resistance?

  16. Bacterial Resistance to Antibiotics  Enzymes secreted (exo-enzyme)  Enzymes not secreted (endo-enzymes)  Deletion of target molecules  Change in cell permeability  Change in target molecule affinity  Speed-up of synthesis and metabolism  Others

  17. Mechanism of resistance • Selection pressure ( not only in health institutions) • Genetic recombination ( especially conjugation mediated by plasmid)

  18. Improper prescription of antibiotics • Antibiotic prescription for non-bacterial infection • Prophylaxis application of antibiotics • Local application of antibiotics • Over use of wide-spectrum antibiotics • Long-term use of antibiotics • Antibiotic abuse in agriculture production

  19. Modern Medicine Is Not Possible Without Effective Antibiotics Hip replacement Organ transplants Cancer chemotherapy Care of preterm babies

  20. The survival of the fittest

  21. Horisontal spread of resistance genes Spread of resistance between species

  22. Barrier to the development of new antibiotics • Short marketing life of the product because of resistance • Difficult R&D 1、qualified strain 2、resources to support R&D 3、long term research and translation • Adverse reactions • Expense for health care

  23. The outcome of resistance development (From the view point of bacteria cells)  Uneconomic state of cell metabolism  Slow-down of proliferation  deletion of some pathogenic abilities  Avoiding harms from drugs

  24. Antibiotic sensitivity test MIC & MBC  Broth dilution  Agar dilution  Disk diffusion  Standard requirements

  25. Antibiotic sensitivity test Standard requirements: a.Depth: 4mm b.  Inoculates: 105 cell/ml c.   Incubation: 37℃, 18 hours

  26. Antibiotic Sensitivity Test  How to explain the results?  How to avoid misleading of clinicians?  How to standardize the test?

  27. Reading and evaluation of sensitivity test 1、Physical and chemical profile of the medicine 2、Metabolic process 3、Identification of sensitivity & resistance 4、Q.C. 5、Who is responsible for those work?

More Related